Acromec, a Singapore-based established specialist engineering service provider in the field of controlled environments serving mainly the healthcare, biomedical, pharmaceutical, research and academia sectors, has secured three engineering, procurement and construction (EPC) contracts totalling approximately S$17.02 million (US$12.8m).
Project 1
The first project, which has a contract value of US$8.3m, involves ducting and piping works for the air conditioning and mechanical ventilation system at the Singapore Institute of Technology's new campus at Punggol North.
This project is scheduled to commence in the third quarter of the financial year ending 30 September 2021 (FY2021) and is expected to be completed in the second quarter of the financial year ending 30 September 2023.
Project 2
The second project, which has a combined contract value of US$3.0m, involves the supply, installation, testing, and commissioning of cleanrooms systems, as well as heating, ventilation, and air conditioning (HVAC) systems for a customer in the healthcare sector.
The project is scheduled to commence in the third quarter of FY2021 and is expected to be completed by the end of FY2021.
Project 3
The third project, also for a customer in the healthcare sector, has a contract value of US$1.6m and involves the design and build of a new medical centre with an operating theatre for Luma Women's Imaging Medical Centre.
The project is scheduled to commence in the third quarter of FY2021 and expected to be completed by the end of FY2021.
Lim Say Chin, Executive Chairman and Managing Director of Acromec, said: "We are pleased to have secured these contracts during these challenging times, which is a testament to our customers continued recognition and confidence in our capabilities to deliver quality work. We will continue to work hard and deliver on these projects, and leverage on our established track record and proven expertise to actively pursue more contracts to further grow our business."
The contracts are expected to contribute positively to the earnings per share and net tangible assets per share of the Group for FY2021.